comparemela.com

Latest Breaking News On - Jon johnsson - Page 2 : comparemela.com

Karo Pharma s rights issue fully subscribed

HUDDINGE, Sweden, April 19, 2022 /PRNewswire/ Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa

United statesNew zealandHong kongUnited kingdomSouth africaKaro pharmaChristoffer lorenzenSkandinaviska enskilda bankenKaro pharma aktiebolagJon johnssonErik penser bankEuropean parliamentEuropean union withdrawalFinancial servicesSwedish companies registration officeRights issue

Karo Pharma publishes prospectus relating to the rights issue and receives approval to change listing venue to Nasdaq First North Growth Market

Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, Singapore, the United States or any other jurisdiction in which the distribution or release would be unlawful or require further registration measures.

United statesNew zealandHong kongUnited kingdomSouth africaKaro pharmaChristoffer lorenzenSkandinaviska enskilda bankenKaro pharma aktiebolagJon johnssonSwedish financial supervisory authorityErik penser bankEuropean parliamentEuropean union withdrawalFinancial servicesSwedish financial supervisory

Karo Pharma publishes prospectus relating to the rights issue and receives approval to change listing venue to Nasdaq First North Growth Market

HUDDINGE, Sweden, March 23, 2022 /PRNewswire/ The prospectus relating to the rights issue in Karo Pharma Aktiebolag ("Karo Pharma") of approximately SEK 2.5 billion (the "Rights Issue") has

United statesNew zealandHong kongUnited kingdomSouth africaKaro pharmaChristoffer lorenzenSkandinaviska enskilda bankenKaro pharma aktiebolagJon johnssonSwedish financial supervisory authorityErik penser bankEuropean parliamentEuropean union withdrawalFinancial servicesSwedish financial supervisory

Karo Pharma receives approval to delist the Company s share from Nasdaq Stockholm in connection with the change of listing venue to Nasdaq First North Growth Market

HUDDINGE, Sweden, March 10, 2022 /PRNewswire/ Karo Pharma Aktiebolag (publ) (the "Company" or "Karo Pharma") announced in a press release on 9 March 2022 that Karo Pharma's Board of Directors

Karo pharmaChristoffer lorenzenJon johnssonPrnewswire karo pharma aktiebolagCompany or karo pharmaPharma aktiebolagNasdaq stockholmNasdaq stockholm first north growth marketNasdaq first north growthNasdaq first north growth marketNasdaq stockholm large

Karo Pharma: Year-end report 2021

HUDDINGE, Sweden, Feb. 25, 2022 /PRNewswire/ Q4, October - December Revenues amounted to MSEK 762.0 (721.2), corresponding to an increase of +6% for the period. The

United kingdomCity ofKaro pharmaChristoffer lorenzenJon johnssonOperating profitPerformance measuresHospital supplyAlpha foodsNorthern europeNasdaq stockholmNasdaq first north

vimarsana © 2020. All Rights Reserved.